
Sunita Reddy
Examiner (ID: 846, Phone: (571)270-5151 , Office: P/3735 )
| Most Active Art Unit | 3791 |
| Art Unit(s) | RD00, 2491, 3791, 3735 |
| Total Applications | 826 |
| Issued Applications | 503 |
| Pending Applications | 83 |
| Abandoned Applications | 269 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19311815
[patent_doc_number] => 12037618
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-16
[patent_title] => PH20 polypeptide variants, formulations and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/327586
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 149964
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327586
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327586 | PH20 polypeptide variants, formulations and uses thereof | May 20, 2021 | Issued |
Array
(
[id] => 18567096
[patent_doc_number] => 20230257425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => VACCINE COMPOSITION FOR PREVENTING OR TREATING INFECTION OF SARS-COV-2
[patent_app_type] => utility
[patent_app_number] => 17/922407
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922407 | VACCINE COMPOSITION FOR PREVENTING OR TREATING INFECTION OF SARS-COV-2 | Apr 28, 2021 | Pending |
Array
(
[id] => 19840150
[patent_doc_number] => 12252519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Crystal structure of a replication protein encoded by a plasmid isolated from a multiple sclerosis patient
[patent_app_type] => utility
[patent_app_number] => 17/242116
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6742
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242116
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242116 | Crystal structure of a replication protein encoded by a plasmid isolated from a multiple sclerosis patient | Apr 26, 2021 | Issued |
Array
(
[id] => 18312583
[patent_doc_number] => 20230116483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHOD FOR PRODUCING PHA USING SEA WATER
[patent_app_type] => utility
[patent_app_number] => 17/907278
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907278 | METHOD FOR PRODUCING PHA USING SEA WATER | Mar 24, 2021 | Pending |
Array
(
[id] => 18266509
[patent_doc_number] => 20230087751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS IN PLANTS
[patent_app_type] => utility
[patent_app_number] => 17/795822
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795822 | RECOMBINANT ADENO-ASSOCIATED VIRAL VECTORS IN PLANTS | Feb 2, 2021 | Pending |
Array
(
[id] => 18469179
[patent_doc_number] => 20230203463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/789977
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -183
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789977
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/789977 | RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE | Dec 27, 2020 | Pending |
Array
(
[id] => 18077393
[patent_doc_number] => 20220403005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/777245
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17777245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/777245 | COMPOSITIONS AND METHODS FOR MODULATING FACTOR VIII FUNCTION | Dec 6, 2020 | Pending |
Array
(
[id] => 18143379
[patent_doc_number] => 20230017228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHOD OF LYOPHILIZATION OF A CRYOGENIZED CELLULAR COMPOSITION CONTAINING DISSOLVED GAS
[patent_app_type] => utility
[patent_app_number] => 17/780336
[patent_app_country] => US
[patent_app_date] => 2020-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17780336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/780336 | METHOD OF LYOPHILIZATION OF A CRYOGENIZED CELLULAR COMPOSITION CONTAINING DISSOLVED GAS | Dec 1, 2020 | Pending |
Array
(
[id] => 18020584
[patent_doc_number] => 20220372083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => SARS-COV-2 RECOMBINANT N PROTEIN, AND PREPARATION METHOD AND PURIFICATION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/767033
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767033
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767033 | SARS-COV-2 RECOMBINANT N PROTEIN, AND PREPARATION METHOD AND PURIFICATION METHOD THEREFOR | Nov 19, 2020 | Pending |
Array
(
[id] => 18036613
[patent_doc_number] => 20220380828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => MICROBIAL DETECTION PLATFORM
[patent_app_type] => utility
[patent_app_number] => 17/773667
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773667
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773667 | MICROBIAL DETECTION PLATFORM | Nov 4, 2020 | Abandoned |
Array
(
[id] => 17991272
[patent_doc_number] => 20220357309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS
[patent_app_type] => utility
[patent_app_number] => 17/774215
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774215 | METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS | Nov 3, 2020 | Pending |
Array
(
[id] => 18019016
[patent_doc_number] => 20220370515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => MEDICAL COMPOSITIONS AND THEIR USE IN TREATING PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 17/773403
[patent_app_country] => US
[patent_app_date] => 2020-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773403 | MEDICAL COMPOSITIONS AND THEIR USE IN TREATING PANCREATIC CANCER | Oct 27, 2020 | Pending |
Array
(
[id] => 19300004
[patent_doc_number] => 20240228573
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE
[patent_app_type] => utility
[patent_app_number] => 17/769630
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769630 | METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE | Oct 15, 2020 | Pending |
Array
(
[id] => 19300004
[patent_doc_number] => 20240228573
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2024-07-11
[patent_title] => METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE
[patent_app_type] => utility
[patent_app_number] => 17/769630
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769630
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769630 | METHOD FOR PRODUCING FUSION PROTEIN OF SERUM ALBUMIN AND GROWTH HORMONE | Oct 14, 2020 | Pending |
Array
(
[id] => 18065511
[patent_doc_number] => 20220396598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => PEPTIDE PURIFICATION FORMULATIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/764354
[patent_app_country] => US
[patent_app_date] => 2020-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764354
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764354 | PEPTIDE PURIFICATION FORMULATIONS AND METHODS | Oct 12, 2020 | Pending |
Array
(
[id] => 20414328
[patent_doc_number] => 12497600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Biosynthesis of cannabinoids from cannabigerolic acid using novel cannabinoid synthases
[patent_app_type] => utility
[patent_app_number] => 17/767764
[patent_app_country] => US
[patent_app_date] => 2020-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 0
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767764 | Biosynthesis of cannabinoids from cannabigerolic acid using novel cannabinoid synthases | Oct 11, 2020 | Issued |
Array
(
[id] => 18360487
[patent_doc_number] => 20230142078
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => ENHANCEMENT AND STABILISATION OF PROTEOLYTIC ACTIVITY OF PROTEASES
[patent_app_type] => utility
[patent_app_number] => 17/767520
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767520 | ENHANCEMENT AND STABILISATION OF PROTEOLYTIC ACTIVITY OF PROTEASES | Oct 7, 2020 | Pending |
Array
(
[id] => 18581585
[patent_doc_number] => 20230263837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => THERAPEUTIC EFFICACY BY PULMONARY DELIVERY OF LIVE ATTENUATED MYCOBACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/764127
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764127
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764127 | THERAPEUTIC EFFICACY BY PULMONARY DELIVERY OF LIVE ATTENUATED MYCOBACTERIA | Sep 27, 2020 | Pending |
Array
(
[id] => 18020997
[patent_doc_number] => 20220372496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => NANO-PERFORATOR HAVING IMPROVED ANTI-VIRAL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/762988
[patent_app_country] => US
[patent_app_date] => 2020-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762988
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762988 | NANO-PERFORATOR HAVING IMPROVED ANTI-VIRAL ACTIVITY | Sep 21, 2020 | Pending |
Array
(
[id] => 18093426
[patent_doc_number] => 20220411767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => MODIFIED KLENOW FRAGMENT AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/776490
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9874
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776490
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776490 | Modified klenow fragment and application thereof | Sep 9, 2020 | Issued |